naringenin has been researched along with Insulin Resistance in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (5.88) | 29.6817 |
2010's | 9 (52.94) | 24.3611 |
2020's | 7 (41.18) | 2.80 |
Authors | Studies |
---|---|
Angelotti, A; Belury, MA; Cole, RM; Ni, A; Nishikawa, Y; Snoke, DB; Vodovotz, Y | 1 |
Liu, J; Xu, W | 1 |
Domínguez-Avila, JA; González-Aguilar, GA; López-Almada, G; Mejía-León, ME; Robles-Sánchez, M; Salazar-López, NJ | 1 |
Coulter, AA; Coulter, CR; Cusimano, LA; Ghosh, S; Greenway, FL; He, Y; James, SL; Rebello, CJ; Zhang, D | 1 |
Antonelli, A; Balercia, G; Giordani, C; Matacchione, G; Olivieri, F; Petrelli, M; Pieroni, A; Rippo, MR; Sabbatinelli, J; Scarpa, ES; Silvetti, F | 1 |
Geng, X; Li, Y; Song, Y; Tan, L; Wan, L; Wang, M; Xiang, Y; Yu, G | 1 |
Bai, J; Cao, X; Du, H; Guo, J; Li, S; Su, X; Sun, Y; Wang, T; Yang, J; Zhang, G; Zhang, Y | 1 |
Carani Venkatraman, A; Mutlur Krishnamoorthy, R | 1 |
Cheng, Y; Jia, B; Li, X; Wang, Y; Yi, X; Yu, D; Yu, G | 1 |
Cao, F; Cao, P; Cheng, Y; He, Y; Jia, B; Meng, X; Wang, Y; Yang, C; Yu, D; Yu, G | 1 |
Kurokawa, M; Sugita, C; Tsuhako, R; Yoshida, H | 1 |
Lappas, M; Nguyen-Ngo, C; Willcox, JC | 1 |
Liang, J; Ma, S; Pan, C; Qin, W; Ren, B; Wang, L; Wang, S; Wu, F; Zeng, B | 1 |
Allister, EM; Edwards, JY; Hegele, RA; Huff, MW; Markle, JM; Mulvihill, EE; Sawyez, CG; Sutherland, BG; Telford, DE | 1 |
Kai, H; Kawai, K; Ogata, K; Shuto, T; Takamura, N; Tokunaga, J; Yoshida, H | 1 |
Anuradha, CV; Kannappan, S; Palanisamy, N | 1 |
Assini, JM; Chhoker, S; Edwards, JY; Felder, SL; Gros, R; Huff, MW; Mulvihill, EE; Sawyez, CG; Sutherland, BG; Telford, DE | 1 |
1 review(s) available for naringenin and Insulin Resistance
Article | Year |
---|---|
Could Naringenin Participate as a Regulator of Obesity and Satiety?
Topics: Diabetes Mellitus, Type 2; Flavanones; Humans; Inflammation; Insulin Resistance; Non-alcoholic Fatty Liver Disease; Obesity | 2023 |
16 other study(ies) available for naringenin and Insulin Resistance
Article | Year |
---|---|
Dietary Naringenin Preserves Insulin Sensitivity and Grip Strength and Attenuates Inflammation but Accelerates Weight Loss in a Mouse Model of Cancer Cachexia.
Topics: Animals; Cachexia; Diet; Flavanones; Hand Strength; Inflammation; Insulin Resistance; Mice; Muscle, Skeletal; Neoplasms; Quality of Life; Weight Loss | 2021 |
Naringenin and morin reduces insulin resistance and endometrial hyperplasia in the rat model of polycystic ovarian syndrome through enhancement of inflammation and autophagic apoptosis.
Topics: Animals; Antioxidants; Apoptosis; Autophagy; Cell Line, Tumor; Cytokines; Drug Therapy, Combination; Endometrial Hyperplasia; Female; Flavanones; Flavonoids; Humans; Inflammation; Insulin Resistance; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Polycystic Ovary Syndrome; Rats; Signal Transduction | 2022 |
Naringenin and β-carotene convert human white adipocytes to a beige phenotype and elevate hormone- stimulated lipolysis.
Topics: Adipocytes, White; beta Carotene; Glucose; Hormones; Humans; Insulin Resistance; Lipolysis; Obesity; Phenotype; PPAR gamma; Triglycerides | 2023 |
The Combination of Natural Molecules Naringenin, Hesperetin, Curcumin, Polydatin and Quercetin Synergistically Decreases SEMA3E Expression Levels and DPPIV Activity in In Vitro Models of Insulin Resistance.
Topics: Curcumin; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Flavanones; Humans; Insulin; Insulin Resistance; Quercetin; Semaphorins | 2023 |
Naringenin alleviates the excessive lipid deposition of polycystic ovary syndrome rats and insulin-resistant adipocytes by promoting PKGIα.
Topics: Adipocytes; Animals; Cyclic GMP-Dependent Protein Kinase Type I; Female; Glucose; Humans; Insulin; Insulin Resistance; Lipids; Polycystic Ovary Syndrome; Rats | 2023 |
Naringenin improves insulin sensitivity in gestational diabetes mellitus mice through AMPK.
Topics: Adiponectin; AMP-Activated Protein Kinases; Animals; Blood Glucose; Diabetes, Gestational; Female; Flavanones; Glucose Tolerance Test; Glucose Transporter Type 4; Insulin; Insulin Resistance; Mice; Pregnancy; Protein Transport; Reactive Oxygen Species; Signal Transduction | 2019 |
Polyphenols activate energy sensing network in insulin resistant models.
Topics: AMP-Activated Protein Kinases; Animals; Blood Glucose; Cell Differentiation; Cell Line; Cell Survival; Diabetes Mellitus, Type 2; Disease Models, Animal; Energy Metabolism; Flavanones; Glucose Transporter Type 4; Insulin; Insulin Resistance; Male; Metformin; Muscle Fibers, Skeletal; Palmitates; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phosphorylation; Polyphenols; Quercetin; Rats; Rats, Wistar; Sirtuin 1 | 2017 |
Naringenin improve hepatitis C virus infection induced insulin resistance by increase PTEN expression via p53-dependent manner.
Topics: Animals; Cell Line, Tumor; Flavanones; Gene Expression; Hepatitis C; Humans; Insulin Resistance; Mice; Mice, Inbred C57BL; PTEN Phosphohydrolase; Random Allocation; Tumor Suppressor Protein p53 | 2018 |
Naringenin ameliorates insulin resistance by modulating endoplasmic reticulum stress in hepatitis C virus-infected liver.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Endoplasmic Reticulum Stress; Endoribonucleases; Flavanones; Gene Expression Regulation; Hepacivirus; Hepatitis C; Humans; Insulin Resistance; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Protein Serine-Threonine Kinases | 2019 |
Naringenin suppresses neutrophil infiltration into adipose tissue in high-fat diet-induced obese mice.
Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue; Animals; Cell Line; Chemokine CCL2; Chemokine CCL7; Chemokine CXCL2; Coculture Techniques; Diabetes Mellitus, Type 2; Diet, High-Fat; Flavanones; Inflammation; Insulin Resistance; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Neutrophil Infiltration; Obesity; RAW 264.7 Cells | 2020 |
Anti-Diabetic, Anti-Inflammatory, and Anti-Oxidant Effects of Naringenin in an In Vitro Human Model and an In Vivo Murine Model of Gestational Diabetes Mellitus.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cesarean Section; Diabetes, Gestational; Disease Models, Animal; Female; Flavanones; Humans; Hypoglycemic Agents; Insulin Resistance; Intra-Abdominal Fat; Mice; Muscle, Skeletal; Placenta; Pregnancy; Tumor Necrosis Factor-alpha | 2019 |
Apigenin and naringenin regulate glucose and lipid metabolism, and ameliorate vascular dysfunction in type 2 diabetic rats.
Topics: Animals; Anti-Inflammatory Agents; Aorta, Thoracic; Apigenin; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Fasting; Flavanones; Glucose Tolerance Test; Human Umbilical Vein Endothelial Cells; Humans; Insulin Resistance; Intercellular Adhesion Molecule-1; Lipid Metabolism; Lipid Peroxidation; Male; NF-kappa B; Nitric Oxide; Phenylephrine; Rats; Rats, Sprague-Dawley; RNA, Messenger; Vasoconstriction; Vasodilation | 2016 |
Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance.
Topics: Alanine Transaminase; Animals; Anti-Ulcer Agents; Apolipoproteins B; Aspartate Aminotransferases; Blood Glucose; Body Weight; Dietary Fats; DNA, Mitochondrial; Dyslipidemias; Energy Intake; Estrogen Antagonists; Flavanones; Glucose Tolerance Test; Insulin; Insulin Resistance; Lipoproteins, VLDL; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, LDL; Triglycerides | 2009 |
The citrus flavonoids hesperetin and naringenin block the lipolytic actions of TNF-alpha in mouse adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Citrus; Fatty Acids, Nonesterified; Flavanones; Flavonoids; Hesperidin; Insulin Resistance; Lipolysis; Mice; Tumor Necrosis Factor-alpha | 2010 |
Suppression of hepatic oxidative events and regulation of eNOS expression in the liver by naringenin in fructose-administered rats.
Topics: 2,4-Dinitrophenol; Aldehydes; Animals; Antioxidants; Apoptosis; Blood Glucose; Diet; Flavanones; Fructose; Hepatocytes; Insulin; Insulin Resistance; Liver; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidative Stress; Rats; Rats, Wistar; Tyrosine | 2010 |
Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr⁻/⁻ mice.
Topics: Animals; Atherosclerosis; Cholesterol; Fatty Liver; Flavanones; Flavonoids; Inflammation; Insulin Resistance; Male; Mice; Mice, Knockout; Receptors, LDL | 2013 |